Get complete Patent Opposition Report for Array Biopharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Array Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3702351Nov 22, 2023Formulation Comprising A Mek Inhibitor2
EP3463345Nov 2, 2022Pharmaceutical Combinations2
EP3400943Dec 2, 2020Compounds For Use In The Treatment Of Erbb2+ Brain Cancer2
EP3000810Jul 19, 2017N3 Alkylated Benzimidazole Derivative As Mek Inhibitor1